Charles Schwab’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $907K | Sell |
56,702
-9,148
| -14% | -$146K | ﹤0.01% | 2929 |
|
|
2025
Q1 | $1M | Buy |
65,850
+1,791
| +3% | +$27.2K | ﹤0.01% | 2844 |
|
|
2024
Q4 | $1.3M | Buy |
64,059
+488
| +0.8% | +$9.9K | ﹤0.01% | 2820 |
|
|
2024
Q3 | $1.63M | Buy |
63,571
+2,147
| +3% | +$55.2K | ﹤0.01% | 2761 |
|
|
2024
Q2 | $790K | Buy |
+61,424
| New | +$790K | ﹤0.01% | 3019 |
|
|
2023
Q4 | – | Sell |
-1,371
| Closed | -$38.5K | – | 3568 |
|
|
2023
Q3 | $38.5K | Hold |
1,371
| – | – | ﹤0.01% | 3428 |
|
|
2023
Q2 | $41.7K | Sell |
1,371
-3,678
| -73% | -$112K | ﹤0.01% | 3438 |
|
|
2023
Q1 | $94.9K | Hold |
5,049
| – | – | ﹤0.01% | 3256 |
|
|
2022
Q4 | $51.5K | Sell |
5,049
-354
| -7% | -$3.61K | ﹤0.01% | 3351 |
|
|
2022
Q3 | $143K | Hold |
5,403
| – | – | ﹤0.01% | 3197 |
|
|
2022
Q2 | $244K | Buy |
5,403
+197
| +4% | +$8.9K | ﹤0.01% | 3217 |
|
|
2022
Q1 | $513K | Buy |
5,206
+235
| +5% | +$23.2K | ﹤0.01% | 3095 |
|
|
2021
Q4 | $761K | Buy |
4,971
+2,730
| +122% | +$418K | ﹤0.01% | 3014 |
|
|
2021
Q3 | $304K | Hold |
2,241
| – | – | ﹤0.01% | 3264 |
|
|
2021
Q2 | $330K | Buy |
+2,241
| New | +$330K | ﹤0.01% | 3225 |
|